New Edge Advisors, LLC Vbi Vaccines Inc Transaction History

New Edge Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.38 - $22.5 $3,794 - $224,685	9,986 New	9,986 $3,000
Q3 2021 Oct 29, 2021	SELL	$2.8 - $3.72 $28,501 - $37,865	-10,179 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$2.91 - $4.32 $509 - $756	-175 Reduced 1.69%	10,179 $32,000
Q3 2020 Nov 03, 2020	SELL	$2.77 - $6.17 $8,099 - $18,041	-2,924 Reduced 22.02%	10,354 $30,000
Q2 2020 Jul 29, 2020	BUY	$0.87 - $3.13 $11,551 - $41,560	13,278 New	13,278 $41,000
Q1 2020 May 04, 2020	SELL	$0.73 - $1.91 $9,692 - $25,360	-13,278 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$0.65 - $2.12 $8,630 - $28,149	13,278 New	13,278 $16,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.